Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.31 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30554093 | 0.84 | NPY5R (0.32) | NPY5RCA2TLR8TLR7TSHR | |
| SCHEMBL25213963 | 0.79 | PGK1 (0.36) | — | |
| SCHEMBL15699765 | 0.73 | MAPT (0.52) | — | |
| SCHEMBL26947058 | 0.73 | PTPN1 (0.46) | CA2 | |
| SCHEMBL30486708 | 0.72 | MAOB (0.44) | CA2 | |
| SCHEMBL16666119 | 0.72 | PTPN1 (0.46) | CA2 | |
| SCHEMBL26947064 | 0.72 | MAOB (0.44) | CA2 | |
| SCHEMBL30554109 | 0.71 | MAOB (0.37) | — | |
| SCHEMBL17038133 | 0.71 | CYP1A2 (0.49) | CA2TSHR | |
| SCHEMBL30132337 | 0.71 | CYP1A2 (0.49) | CA2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313576-A1 | COMPOUND FOR PHOTOOXYGENATION CATALYST AND MEDICINAL COMPOSITION CONTAINING SAME | THE UNIVERSITY OF TOKYO (JP) | 2025-10-09 | — | — | US | disclosed |
| WO-2023100942-A1 | COMPOUND FOR PHOTOOXYGENATION CATALYST AND MEDICINAL COMPOSITION CONTAINING SAME | 国立大学法人 東京大学 | 2023-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250313576-A1 | COMPOUND FOR PHOTOOXYGENATION CATALYST AND MEDICINAL COMPOSITION CONTAINING SAME | MAPT, APP, PYGB | NPY5R 2658/4885CA2 913/4885TLR8 3547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.